Zyloprim and Neupogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zyloprim (allopurinol) and Neupogen (filgrastim). Common drug interactions include constipation among females and pleural effusion among males.

The phase IV clinical study analyzes what interactions people have when they take Zyloprim and Neupogen. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Zyloprim?

Zyloprim has active ingredients of allopurinol. It is often used in gout. eHealthMe is studying from 5,638 Zyloprim users. Check the latest studies of Zyloprim.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.



On Jul, 08, 2026

44 people who take Zyloprim and Neupogen together, and have interactions are studied.

Zyloprim and Neupogen drug interactions.

What are the common drug interactions of Zyloprim and Neupogen, by gender? *:

female:

  1. Constipation
  2. Multiple myeloma (cancer of the plasma cells)
  3. Oral pain
  4. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  5. Anxiety
  6. Arthralgia (joint pain)
  7. Asthenia (weakness)
  8. Asthma
  9. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  10. Blood alkaline phosphatase increased

male:

  1. Pleural effusion (water on the lungs)
  2. Blood creatinine increased
  3. Bone marrow failure
  4. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  5. Hypoxia (low oxygen in tissues)
  6. Pericardial effusion (fluid around the heart)
  7. Abdominal pain
  8. Atelectasis (partial or complete collapse of the lung)
  9. Cardiac failure congestive
  10. Dry skin

What are the common drug interactions of Zyloprim and Neupogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  2. Blood creatinine increased
  3. Blood lactic acid increased
  4. Blood urea increased
  5. Bone marrow failure
  6. Bradycardia (abnormally slow heart action)
  7. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  8. Cytokine storm (over-protective immune response that can actually be fatal)
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Haematuria (presence of blood in urine)

20-29:

n/a

30-39:

n/a

40-49:

  1. Hypertension (high blood pressure)
  2. Anxiety
  3. Arthralgia (joint pain)
  4. Asthenia (weakness)
  5. Asthma
  6. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  7. Back pain
  8. Blood alkaline phosphatase increased
  9. Blood creatinine increased
  10. Chest pain

50-59:

  1. Dry skin
  2. Dyspnoea (difficult or laboured respiration)
  3. Heart rate increased
  4. Insomnia (sleeplessness)
  5. Klebsiella infection
  6. Localised oedema (fluid retention in a particular part of the body)
  7. Lymphocyte count increased
  8. Mean cell volume increased (more than normal average red blood cell volume)
  9. Mean platelet volume decreased (less than normal average size of platelet cells in blood)
  10. Monocyte count increased

60+:

  1. Aphasia (damage to the parts of the brain that control language)
  2. Tremor (trembling or shaking movements in one or more parts of your body)
  3. Pneumonia
  4. Atelectasis (partial or complete collapse of the lung)
  5. Constipation
  6. Diarrhoea
  7. Fatigue (feeling of tiredness)
  8. Fluid overload (too much fluid in the blood)
  9. Hypoxia (low oxygen in tissues)
  10. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)

What are the existing conditions these people have? *

  1. Bone Marrow Conditioning Regimen: 8 people, 18.18%
  2. Nausea (feeling of having an urge to vomit): 8 people, 18.18%
  3. Pain: 6 people, 13.64%
  4. Nausea And Vomiting: 6 people, 13.64%
  5. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 6 people, 13.64%
  6. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 11.36%
  7. Stress And Anxiety: 5 people, 11.36%
  8. Multiple Myeloma (cancer of the plasma cells): 4 people, 9.09%
  9. Insomnia (sleeplessness): 4 people, 9.09%
  10. Indigestion: 4 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Zyloprim and Neupogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zyloprim and Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zyloprim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zyloprim and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neupogen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on allopurinol and filgrastim (the active ingredients of Zyloprim and Neupogen, respectively), and Zyloprim and Neupogen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: